using Human decidua stromal cells for the treatment of acute respiratory distress syndrome (ARDS), Phase 2

Breast Cancer Research Center (BCRC), Motamed Cancer Institute, Tehran University of Medical science0 个研究点目标入组 15 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Patients over 18 years of age; Diagnosis is done by Berlin definition; The disease is acute; Bilateral lungs with pulmonary edema are evident on X-ray; The patient does not have a history of heart failure; PaO02 / FiO2 less than 200 while the patient is under mechanical ventilation via endotracheal tube or tracheostomy tube with positive end-expiratory pressure at least 8 inches of water; A fungal infection does not exist.
•Exclusion criteria: If three days have passed from the onset of the disease; Any disease history of the vital organs such as heart disease, kidney or liver; Pregnancy; Pulmonary hypertension; Cancer; AIDS; seronegative for hepatitis A and B; seronegative for syphilis; Symptoms of pulmonary embolism.

发起方

Breast Cancer Research Center (BCRC), Motamed Cancer Institute, Tehran University of Medical science